Neuromod Names New CSO To Complete TENT-A Tinnitus Trial And Advance Noninvasive Neuromodulation Platform
Executive Summary
Neuromod, a Dublin, Ireland-based emerging medical technology firm focusing on noninvasive neuromodulation technologies, has named neurostimulation expert Hubert Lim as its new CSO to conclude the company's TENT-A tinnitus trial in Ireland and Germany.
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.
Philips Portfolio Includes ‘No Single Product That Does Not Use A Type Of AI,’ Says CEO And AI Thought Leader Roy Jakobs
Philips CEO Roy Jakobs talks to Medtech Insight about the medtech firm’s decade-long history of embedding AI into its products and what he expects from the newly released draft framework by the National Academy of Medicine, which he helped develop as co-chair of the Steering Committee.